Literature DB >> 24257597

Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

Yacine Abed1, Andrés Pizzorno, Xavier Bouhy, Chantal Rhéaume, Guy Boivin.   

Abstract

Neuraminidase (NA) mutations conferring resistance to NA inhibitors (NAIs) generally compromise the fitness of influenza viruses. The only NAI-resistant virus that widely spread in the population, the A/Brisbane/59/2007 (H1N1) strain, contained permissive mutations that restored the detrimental effect caused by the H275Y change. Computational analysis predicted other permissive NA mutations for A(H1N1)pdm09 viruses. Here, we investigated the effect of T289M and N369K mutations on the viral fitness of the A(H1N1)pdm09 H275Y variant. Recombinant wild-type (WT) A(H1N1)pdm09 and the H275Y, H275Y/T289M, H275Y/N369K, and H275Y/V241I/N369K (a natural variant) NA mutants were generated by reverse genetics. Replication kinetics were performed by using ST6GalI-MDCK cells. Virulence was assessed in C57BL/6 mice, and contact transmission was evaluated in ferrets. The H275Y mutation significantly reduced viral titers during the first 12 to 36 h postinfection (p.i.) in vitro. Nevertheless, the WT and H275Y viruses induced comparable mortality rates, weight loss, and lung titers in mice. The T289M mutation eliminated the detrimental effect caused by the H275Y change in vitro while causing greater weight loss and mortality in mice, with significantly higher lung viral titers on days 3 and 6 p.i. than with the H275Y mutant. In index ferrets, the WT, H275Y, H275Y/T289M, and H275Y/V241I/N369K recombinants induced comparable fever, weight loss, and nasal wash viral titers. All tested viruses were transmitted at comparable rates in contact ferrets, with the H275Y/V241I/N369K recombinant demonstrating higher nasal wash viral titers than the H275Y mutant. Permissive mutations may enhance the fitness of A(H1N1)pdm09 H275Y viruses in vitro and in vivo. The emergence of such variants should be carefully monitored.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257597      PMCID: PMC3911590          DOI: 10.1128/JVI.02681-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

Authors:  Mariana Baz; Yacine Abed; Jesse Papenburg; Xavier Bouhy; Marie-Eve Hamelin; Guy Boivin
Journal:  N Engl J Med       Date:  2009-11-11       Impact factor: 91.245

3.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

4.  Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.

Authors:  Christopher W Seibert; Michael Kaminski; Jennifer Philipp; Dennis Rubbenstroth; Randy A Albrecht; Folker Schwalm; Silke Stertz; Rafael A Medina; Georg Kochs; Adolfo García-Sastre; Peter Staeheli; Peter Palese
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

5.  Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.

Authors:  Susu Duan; David A Boltz; Patrick Seiler; Jiang Li; Karoline Bragstad; Lars P Nielsen; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

6.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

7.  Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.

Authors:  Mariana Baz; Yacine Abed; Philippe Simon; Marie-Eve Hamelin; Guy Boivin
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

8.  Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.

Authors:  Marie-Eve Hamelin; Mariana Baz; Yacine Abed; Christian Couture; Philippe Joubert; Edith Beaulieu; Nathalie Bellerose; Martin Plante; Corey Mallett; Gregg Schumer; Gary P Kobinger; Guy Boivin
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

9.  Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.

Authors:  Maki Kiso; Kyoko Shinya; Masayuki Shimojima; Ryo Takano; Kei Takahashi; Hiroaki Katsura; Satoshi Kakugawa; Mai Thi Quynh Le; Makoto Yamashita; Yousuke Furuta; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Authors:  Adam Meijer; Angie Lackenby; Olav Hungnes; Bruno Lina; Sylvie van-der-Werf; Brunhilde Schweiger; Matthias Opp; John Paget; Jan van-de-Kassteele; Alan Hay; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more
  22 in total

1.  Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.

Authors:  Emi Takashita; Maki Kiso; Seiichiro Fujisaki; Masaru Yokoyama; Kazuya Nakamura; Masayuki Shirakura; Hironori Sato; Takato Odagiri; Yoshihiro Kawaoka; Masato Tashiro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

2.  Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.

Authors:  Elma H Akand; Kevin M Downard
Journal:  J Mol Evol       Date:  2018-10-09       Impact factor: 2.395

3.  Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Joyce Jones; Juan A De La Cruz; Katrina Sleeman; Daisuke Tamura; Ha T Nguyen; Ho-Sheng Wu; Feng-Yee Chang; Ming-Tsan Liu; Alicia M Fry; Nancy J Cox; Julie M Villanueva; Charles T Davis; Larisa V Gubareva
Journal:  J Infect Dis       Date:  2014-08-14       Impact factor: 5.226

4.  Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.

Authors:  Andrés Pizzorno; Yacine Abed; Pier-Luc Plante; Julie Carbonneau; Mariana Baz; Marie-Ève Hamelin; Jacques Corbeil; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

5.  E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.

Authors:  Arnaud G L'Huillier; Yacine Abed; Tom J Petty; Samuel Cordey; Yves Thomas; Xavier Bouhy; Manuel Schibler; Audrey Simon; Yves Chalandon; Christian van Delden; Evgeny Zdobnov; Patricia Boquete-Suter; Guy Boivin; Laurent Kaiser
Journal:  J Infect Dis       Date:  2015-05-17       Impact factor: 5.226

Review 6.  Alternative antiviral approaches to combat influenza A virus.

Authors:  Ka Heng Wong; Sunil K Lal
Journal:  Virus Genes       Date:  2022-10-19       Impact factor: 2.198

7.  Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.

Authors:  Li Jiang; Neha Samant; Ping Liu; Mohan Somasundaran; Jeffrey D Jensen; Wayne A Marasco; Timothy F Kowalik; Celia A Schiffer; Robert W Finberg; Jennifer P Wang; Daniel N A Bolon
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

8.  Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.

Authors:  Weijuan Huang; Xiyan Li; Yanhui Cheng; Minju Tan; Junfeng Guo; Hejiang Wei; Xiang Zhao; Yu Lan; Ning Xiao; Zhao Wang; Dayan Wang; Yuelong Shu
Journal:  Virol J       Date:  2015-06-24       Impact factor: 4.099

9.  Dual oxidase 1 promotes antiviral innate immunity.

Authors:  Demba Sarr; Aaron D Gingerich; Nuha Milad Asthiwi; Faris Almutairi; Giuseppe A Sautto; Jeffrey Ecker; Tamás Nagy; Matthew B Kilgore; Joshua D Chandler; Ted M Ross; Ralph A Tripp; Balázs Rada
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

10.  Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study.

Authors:  Laetitia Canini; Jessica M Conway; Alan S Perelson; Fabrice Carrat
Journal:  PLoS Comput Biol       Date:  2014-04-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.